isradipine is superior to atenolol in reducing systolic bp
TRANSCRIPT
lsradipine is superior to atenolol in reducing systolic BP
lsradip1ne 2.5-1 Omg bid mono therapy (n = 76) produced a greater reduction in systolic BP and an equivalent reduction in diastolic BP compared with atenolol 50-100 mg;day monotherapy (76) 1n a multicentre randomised double-blind trial suggesting that 1sradipine has • ... a favourable effect on arterial compliance ... '. The combination of 1sradipine + atenolol in non-responders produced a good response in 13/14 patients. lsradiplne n1 H .~-pertens,on StudJ' Group A rnult,center e,,aluat1on of the sJ.k:t; ar.,.J elf,cac\, ol ISr.J.dlplne and atenolo! jn tile treatment oi hyoertcnSion .L\m~;rlcan .I:J1Jrna! c:! .~/e-a~~~~~~i:.' 86 ll~l-123 17 Apr 1989 ·ss
12 INPHARMA " 3 Jun 1989 0156-2703/89/0603-0012/0$01.00/0 © ADIS Press